Conjugated estrogens/bazedoxifene

(Duavee®)

Conjugated estrogens/bazedoxifene

Drug updated on 11/10/2023

Dosage FormTablet (oral; 0.45 mg conjugated estrogens and 20 mg bazedoxifene)
Drug ClassHormones
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
  • Indicated for the prevention of postmenopausal osteoporosis.